Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)
Ronjon Chakraverty(University College Hospital), Gabrielle Smith(Cancer Research UK Clinical Trials Unit), Charlotte Gaskell(Cancer Research UK Clinical Trials Unit), Emma Kempshall(University Hospital of Wales), Fiona L. Dignan(St Thomas' Hospital), Ram Malladi(Cambridge University Hospitals NHS Foundation Trust), Adrian Bloor(The Christie NHS Foundation Trust), Victoria Potter(King's College Hospital NHS Foundation Trust), Matthew Collin(Newcastle upon Tyne Hospitals NHS Foundation Trust), Jeff Davies(Queen Mary University of London), Andrea Hodgkinson(University of Birmingham), Simon Gates(Oxford Brookes University), Kavita Raj(Johns Hopkins Hospital), Rebecca Bishop(Cancer Research UK Clinical Trials Unit), Siobhán Smith(Royal College of Surgeons in Ireland)
Cited by 1
Related Papers
Interventions for preventing falls in older people living in the community
|Cochrane Database of Systematic Reviews|2012|3.9k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Midwife-led continuity models versus other models of care for childbearing women
|Cochrane Database of Systematic Reviews|2013|1.2k
Continuous support for women during childbirth
|Cochrane Database of Systematic Reviews|2012|1.2k
Midwife-led continuity models versus other models of care for childbearing women
|Cochrane Database of Systematic Reviews|2016|924